MwanzoEH3 • FRA
add
Amarin Corporation PLC
Bei iliyotangulia
€ 10.30
Bei za siku
€ 10.30 - € 11.10
Bei za mwaka
€ 7.16 - € 11.10
Thamani ya kampuni katika soko
263.54M USD
Wastani wa hisa zilizouzwa
9.00
Uwiano wa bei na mapato
-
Mgao wa faida
-
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 42.02M | -25.66% |
Matumizi ya uendeshaji wa biashara | 41.88M | -7.92% |
Mapato halisi | -15.70M | -57.71% |
Kiwango cha faida halisi | -37.36 | -112.15% |
Mapato kwa kila hisa | -0.40 | -100.00% |
EBITDA | -16.02M | -24.99% |
Asilimia ya kodi ya mapato | -15.16% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 281.79M | -8.56% |
Jumla ya mali | 655.68M | -17.00% |
Jumla ya dhima | 181.99M | -25.44% |
Jumla ya hisa | 473.69M | — |
hisa zilizosalia | 20.71M | — |
Uwiano wa bei na thamani | 0.45 | — |
Faida inayotokana na mali | -6.25% | — |
Faida inayotokana mtaji | -8.55% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -15.70M | -57.71% |
Pesa kutokana na shughuli | -12.46M | 1.13% |
Pesa kutokana na uwekezaji | 12.06M | -57.99% |
Pesa kutokana na ufadhili | -1.12M | 21.53% |
Mabadiliko halisi ya pesa taslimu | -1.51M | -110.30% |
Mtiririko huru wa pesa | -13.50M | 7.29% |
Kuhusu
Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa, a prescription grade omega-3 fatty acid.
In July 2012, their lead-candidate drug named Vascepa received FDA-approval, competing against GlaxoSmithKline's Lovaza. Wikipedia
Ilianzishwa
1 Mac 1989
Makao Makuu
Tovuti
Wafanyakazi
275
